Monoclonal antibody
Fasinumab Type ? Source Human Target HNGF ATC code CAS Number ChemSpider UNII KEGG Formula C 6406 H 9896 N 1700 O 2026 S 46 Molar mass 618 .27−1
Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain.[1] [2]
This drug was developed in collaboration by Teva Pharmaceutical Industries and Regeneron Pharmaceuticals.
It is currently at Phase III trials (NCT03245008, NCT02683239, and NCT03161093).[3]
^ "Fasinumab" (PDF) . Statement On A Nonproprietary Name Adopted By The USAN Council . American Medical Association. ^ Tiseo PJ, Ren H, Mellis S (2014). "Fasinumab (REGN475), an antinerve growth factor monoclonal antibody, for the treatment of acute sciatic pain: results of a proof-of-concept study". Journal of Pain Research . 7 : 523–530. doi:10.2147/JPR.S65974 . PMC 4155988 . PMID 25210473. ^ Oo WM, Hunter DJ (November 2021). "Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review". BioDrugs . 35 (6): 611–641. doi:10.1007/s40259-021-00504-8. PMID 34807432. S2CID 244509341.
Last Update: 2023-09-26T14:19:26Z
Fasinumab is a human monoclonal antibody designed for the treatment of acute sciatic pain. This drug was developed in collaboration by Teva Pharmaceutical...
Word Count : 142
Last Update: 2024-04-22T02:25:33Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 5993
Last Update: 2024-03-21T22:16:34Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 3413
Last Update: 2024-05-14T06:10:24Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 8668
Last Update: 2024-05-16T06:55:25Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 15756
Last Update: 2024-04-11T00:19:54Z
osteoarthritis, and chronic lower back pain. Two NGF inhibitors (tanezumab, and fasinumab ) are undergoing clinical trials as potential treatments for pain disorders...
Word Count : 515
Last Update: 2024-04-26T23:53:23Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 2786
Last Update: 2024-04-07T05:47:37Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1489
Last Update: 2024-02-28T03:22:37Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1735
Last Update: 2024-05-15T00:45:19Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 13791
Last Update: 2024-01-06T04:08:10Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1784
Last Update: 2024-04-27T02:56:13Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 524
Last Update: 2024-01-16T13:19:34Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 421
Last Update: 2024-04-10T06:21:42Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 3010
Last Update: 2024-04-17T06:09:06Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 7144
Last Update: 2024-04-30T04:01:08Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 3935
Last Update: 2024-05-14T09:46:58Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1585
Last Update: 2024-02-26T05:55:48Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 3069
Last Update: 2024-03-10T06:38:02Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1543
Last Update: 2024-05-07T09:10:32Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 6513
Last Update: 2024-03-10T20:20:18Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 4578
Last Update: 2022-06-16T04:46:03Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1081
Last Update: 2024-04-27T21:55:20Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 12661
Last Update: 2024-03-20T04:37:35Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 1808
Last Update: 2024-05-12T22:45:17Z
(SAR-127963) Testosterone Antibodies: Against NGF: ABT-110 (PG110) ASP-6294 Fasinumab Frunevetmab Fulranumab MEDI-578 Ranevetmab Tanezumab Aptamers: Against...
Word Count : 4735
Global Information